Trial intelligence / Profile preview

Phase 3 comparison of TOCOSOL Paclitaxel vs weekly paclitaxel in metastatic breast cancer

2005-002428-33Phase 3Unknown

Sponsor
SONUS Pharmaceuticals, Inc
Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of paclitaxel in breast cancer (2 arms), sponsored by SONUS Pharmaceuticals, Inc. Primary endpoint: Confirmed overall response rate. Status: unknown.

02

Drugs

paclitaxel
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2005-002428-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002428-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call